SCHEMBL3980871

SCHEMBL3980871

C=C(C)C(=O)OC(CC)OP(=O)(OC(CC)OC(=O)C(=C)C)OC(CC)OC(=O)C(=C)C

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
ALDH1A1 P00352 2/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2059970 0.87 TSHR (0.36) TSHRALDH1A1THRB
SCHEMBL2019664 0.87 SMPD1 (0.41) TSHRALDH1A1THRB
SCHEMBL2680754 0.86 ALDH1A1 (0.38) TSHRALDH1A1THRB
SCHEMBL28240308 0.86 SMPD1 (0.40) TSHRALDH1A1THRB
SCHEMBL601418 0.84 TSHR (0.45) TSHRALDH1A1THRB
SCHEMBL6786896 0.83 TSHR (0.41) TSHRALDH1A1THRB
SCHEMBL5068871 0.82 TSHR (0.43) TSHRALDH1A1THRB
SCHEMBL9162961 0.82 TSHR (0.43) TSHRALDH1A1THRB
SCHEMBL180089 0.82 SMPD1 (0.47) TSHR
SCHEMBL27898159 0.82 THRB (0.34) TSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118879207-A High temperature resistant acrylate adhesives 伊利诺斯工具制品有限公司 2024-11-01 CN claimed
EP-0468077-A1 Dental adhesive MITSUBISHI RAYON CO., LTD. (JP) 1992-01-29 EP claimed
JP-6001906-A None JP disclosed
US-20250152772-A1 PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUES COHESIVES (FR) 2025-05-15 US disclosed
CN-113444373-B Composition for modifying asphalt, modified asphalt, method for producing same, and asphalt mixture 李威风 2023-01-24 CN disclosed
CN-113444373-A Composition for modifying asphalt, modified asphalt, method for producing same, and asphalt mixture 李威风 2021-09-28 CN disclosed
US-11028340-B2 Composition for surface treatment, method for producing the same, surface treatment method using composition for surface treatment, and method for producing semiconductor substrate FUJIMI INCORPORATED (JP) 2021-06-08 US disclosed
US-10876073-B2 Composition for surface treatment, and method for surface treatment using the same FUJIMI INCORPORATED 2020-12-29 US disclosed
US-20190177656-A1 COMPOSITION FOR SURFACE TREATMENT, AND METHOD FOR SURFACE TREATMENT USING THE SAME FUJIMI INCORPORATED (JP) 2019-06-13 US disclosed
EP-1882022-B1 AMBIENT CURABLE PROTECTIVE SEALANT LORD CORP (US) 2009-05-06 EP disclosed
EP-1882022-A1 AMBIENT CURABLE PROTECTIVE SEALANT LORD CORPORATION (US) 2008-01-30 EP disclosed
WO-2006125148-A1 AMBIENT CURABLE PROTECTIVE SEALANT LORD CORPORATION (US) 2006-11-23 WO disclosed
US-20060264573-A1 Ambient curable protective sealant LORD CORPORATION 2006-11-23 US disclosed
US-20040259992-A1 Two-component adhesion promoter combination of an unsaturated alkoxysilane and a mercaptoalkyl alkoxysilane, for use in dental prostheses 3M ESPE AG (DE) 2004-12-23 US disclosed
JP-H061906-A PHOTOSENSITIVE RESIN COMPOSITION TAMURA KAKEN KK 1994-01-11 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259992-A1 Two-component adhesion promoter combination of an unsaturated alkoxysilane and a mercaptoalkyl alkoxysilane, for use in dental prostheses ITGA2, ITGB2, ITGA2B TSHR 3882/4885ALDH1A1 453/4885THRB 1594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.